Vitamin D: Exacerbations in Chronic Obstructive Pulmonary Disease (COPD)

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Pacts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Pacts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@kumc.edu.

Get full access to this article

View all access options for this article.

References

Persson

L.J.P.

Aanerud

Hiemstra

P.S.

Hardie

J.A.

Bakke

P.S.

Eagan

T.M.L.

Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLOS One. 2012; 7(6);e38934.

Gold

D.R.

Manson

J.E.

Severe vitamin D deficiency: a prerequisite for COPD responsiveness to vitamin D supplementation. Ann Intern Med. 2012; 156(2): 156–157.

Lehouck

Mathieu

Carremans

High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease. Ann Intern Med. 2012; 156: 105–114.

Qaseem

Wilt

T.J.

Weinberger

S.E.

Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011; 155: 179–191.